four parameter sigmoidal dose-response curve graphpad prism software version 5.04 (GraphPad Software Inc)
90
Structured Review
GraphPad Software Inc
four parameter sigmoidal dose-response curve graphpad prism software version 5.04
Four Parameter Sigmoidal Dose Response Curve Graphpad Prism Software Version 5.04, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/four+parameter+sigmoidal+function/four+parameter+sigmoidal+dose+response+curve+graphpad+prism+software+version+5+04/pmc04833097-273-44-51
Average 90 stars, based on 1 article reviews
Four Parameter Sigmoidal Dose Response Curve Graphpad Prism Software Version 5.04, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/four+parameter+sigmoidal+function/four+parameter+sigmoidal+dose+response+curve+graphpad+prism+software+version+5+04/pmc04833097-273-44-51
Average 90 stars, based on 1 article reviews
four parameter sigmoidal dose-response curve graphpad prism software version 5.04 - by Bioz Stars,
2026-11
90/100 stars
Images
Related Articles
Derivative Assay:Article Title: Dose addition in mixtures of compounds with dissimilar endocrine modes of action in in vitro receptor activation assays and the zebrafish sexual development test. Article Snippet: Background: Human exposure to pesticides is being associated with feminisation for which a decrease of the anogenital distance (AGD) is a sensitive endpoint.. Dose addition for the cumulative risk assessment of pesticides in food is considered sufficiently conservative for combinations of compounds with both similar and dissimilar modes of action (MoA).. Objective: The present study was designed to test the dose addition hypothesis in a binary mixture of endocrine active compounds with a dissimilar mode of action for the endpoint feminisation. Article Title: Extending an In Vitro Panel for Estrogenicity Testing: The Added Value of Bioassays for Measuring Antiandrogenic Activities and Effects on Steroidogenesis Article Snippet: The relative estrogenic potency (REP), defined as the ratio of the concentration of E2 needed to achieve 50% of maximal Software:Article Title: Dose addition in mixtures of compounds with dissimilar endocrine modes of action in in vitro receptor activation assays and the zebrafish sexual development test. Article Snippet: Background: Human exposure to pesticides is being associated with feminisation for which a decrease of the anogenital distance (AGD) is a sensitive endpoint.. Dose addition for the cumulative risk assessment of pesticides in food is considered sufficiently conservative for combinations of compounds with both similar and dissimilar modes of action (MoA).. Objective: The present study was designed to test the dose addition hypothesis in a binary mixture of endocrine active compounds with a dissimilar mode of action for the endpoint feminisation. Article Title: Extending an In Vitro Panel for Estrogenicity Testing: The Added Value of Bioassays for Measuring Antiandrogenic Activities and Effects on Steroidogenesis Article Snippet: The relative estrogenic potency (REP), defined as the ratio of the concentration of E2 needed to achieve 50% of maximal Concentration Assay:Article Title: Dose addition in mixtures of compounds with dissimilar endocrine modes of action in in vitro receptor activation assays and the zebrafish sexual development test. Article Snippet: Background: Human exposure to pesticides is being associated with feminisation for which a decrease of the anogenital distance (AGD) is a sensitive endpoint.. Dose addition for the cumulative risk assessment of pesticides in food is considered sufficiently conservative for combinations of compounds with both similar and dissimilar modes of action (MoA).. Objective: The present study was designed to test the dose addition hypothesis in a binary mixture of endocrine active compounds with a dissimilar mode of action for the endpoint feminisation. Article Title: Extending an In Vitro Panel for Estrogenicity Testing: The Added Value of Bioassays for Measuring Antiandrogenic Activities and Effects on Steroidogenesis Article Snippet: The relative estrogenic potency (REP), defined as the ratio of the concentration of E2 needed to achieve 50% of maximal |